C. Frank Bennett - Feb 2, 2024 Form 4/A - Amendment Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Signature
Patrick R. O'Neil, attorney-in-fact For: C. Frank Bennett
Stock symbol
IONS
Transactions as of
Feb 2, 2024
Transactions value $
-$93,337
Form type
4/A - Amendment
Date filed
9/4/2024, 08:42 PM
Date Of Original Report
Feb 2, 2024
Previous filing
Feb 2, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale -$93.3K -1.89K -2.33% $49.52 79K Feb 2, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4 filed on February 2, 2024 reported 1,853 restricted stock units sold by the reporting person which has been revised by this amendment to reflect the actual amount of shares sold and beneficially owned by Mr. Bennett.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.51 to $49.53 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.